PUBLIC COMPANY
save$PVLAPALVELLA THERAPEUTICS, INC.
$PVLA156.13-0.27%Wayne, PA, USupdated 1d ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
1
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
earnings (1)
Active trials
- phase2A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations
- phase3SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations
- phase2Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations
- phase3VALO-2: Study Evaluating the Safety and Efficacy of PTX022 in the Treatment of Adults With Pachyonychia Congenita
- phase3Phase 2/3 Study Evaluating the Safety and Efficacy of PTX-022 in Treatment of Adults With Pachyonychia Congenita
- phase3A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita
- phase2CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome
Insider activity
source: SEC Form 4open-market buys + sells
- Apr 15, 26SELLGoin Kathleen· Chief Operating Officer−$191K↗
- Apr 15, 26SELLGoin Kathleen· Chief Operating Officer−$189K↗
- Apr 15, 26SELLGoin Kathleen· Chief Operating Officer−$83K↗
- Apr 15, 26SELLGoin Kathleen· Chief Operating Officer−$72K↗
- Apr 15, 26SELLGoin Kathleen· Chief Operating Officer−$13K↗
- Mar 30, 26BUYJENKINS GEORGE M· $50K↗
- Mar 18, 26SELLGoin Kathleen· Chief Operating Officer−$267K↗
- Mar 18, 26SELLGoin Kathleen· Chief Operating Officer−$205K↗
- Mar 18, 26SELLGoin Kathleen· Chief Operating Officer−$36K↗
- Feb 27, 26BUYJENKINS GEORGE M· $500K↗
- Feb 27, 26BUYHERON ELAINE J· $300K↗
- Feb 18, 26SELLGoin Kathleen· Chief Operating Officer−$240K↗
- Feb 18, 26SELLGoin Kathleen· Chief Operating Officer−$102K↗
routine RSU / option mechanics (6)
- Apr 15, 26option exerciseGoin Kathleen · Chief Operating Officer2,148 sh
- Apr 15, 26option exerciseGoin Kathleen · Chief Operating Officer2,154 sh
- Apr 15, 26option exerciseGoin Kathleen · Chief Operating Officer2,154 sh
- Apr 15, 26option exerciseGoin Kathleen · Chief Operating Officer2,148 sh
- Apr 13, 26grantDoux John · 6,000 sh
- Mar 18, 26option exerciseGoin Kathleen · Chief Operating Officer2,148 sh
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 2m ago
Found something off?
comments(0)
5-min edit window · permanent after that